CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Leah M. Mayo

OPENALEX: A5091804865↗ORCID: 0000-0002-0645-4869↗

Affiliations

Organizations

University of Calgaryauthorship · CA

Public evidence

3 connected articles

Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkers.2026 · Europe PMC Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial.2026 · Europe PMC The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial.2025 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Leah M. Mayo - Medical Cannabis Research Engine